Development of a Metabolic Biosignature for Detection of Early Lyme Disease

Abstract

The data provide proof-of-concept that metabolic profiling for early Lyme disease can achieve significantly greater (P < .0001) diagnostic sensitivity than current 2-tier serology, while retaining high specificity.